<DOC>
	<DOCNO>NCT01613196</DOCNO>
	<brief_summary>Tuberculosis ( TB ) remain major public health problem . In extra-pulmonary form , evidence bacteriological cure difficult obtain raise need therapeutic assessment tool . 18F-Fluoro-deoxy-glucose ( FDG ) glucose analogue widely use Positron Emission Tomography ( PET ) . Its uptake high cancer cell inflammatory cell , especially active TB focus . The hypothesis decrease uptake FDG focus TB treatment permit non-invasive monitoring therapeutic response . The main objective describe evolution treatment FDG uptake PET image TB focus patient cure lymph node bone TB . Secondary objective compare decrease FDG uptake accord type location , define frequency localization reveal FDG-PET impact therapeutic management begin end treatment , describe evolution PET patient cure .</brief_summary>
	<brief_title>Positron Emission Tomography Extrapulmonary Tuberculosis</brief_title>
	<detailed_description>Longitudinal observational multicenter pilot study . 55 patient include Total duration study : 51 month . Inclusion period : 27 month Follow period : 18 24 month Number participate center : 11 Average number inclusion per month per center : 1-2</detailed_description>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Tuberculosis , Lymph Node</mesh_term>
	<mesh_term>Tuberculosis , Osteoarticular</mesh_term>
	<mesh_term>Deoxyglucose</mesh_term>
	<criteria>Adults Affiliated social security system `` AME '' Patient inform objective constraint study give inform consent Patient keep lie valid least 30 minute Patient HIV infect , infect , CD4 count &gt; 200/mm3 least 3 month Suspicion concurrent infection Severe immunosuppression case HIV infection Inflammatory disease Pregnant nursing woman Radiation therapy Uncontrolled diabetes Prolonged corticosteroid therapy ( &gt; 20mg/day ) Patient unable sustain inject CT scan MRI</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Extrapulmonary tuberculosis</keyword>
	<keyword>FDG-TEP</keyword>
	<keyword>cohort</keyword>
</DOC>